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NS). However, patients developing AV sclerosis after inclusion had higher mean diastolic 
blood pressure after four years of treatment (83 vs. 80 mmHg, P<O.Ol). The incidence of 
AV stenosis was higher in patients with AV sclerosis compared to those with normal 
valves at baseline after one year (2.8% vs. 0.4%, PcO.001) and four years (6.9% vs. 
0.9%, P-=0.001) of treatment. Conclusion: The prevalence of AV sclerosis and mild AV 
stenosis increased quickly in an elderly high-risk hypertensive population and could not 
be prevented by treatment with losartan. Development of new AV sclerosis or stenosis 
was associated with suboptimal diastolic blood pressure control. Pabents with AV sclero- 
sis had significantly higher risk of progressing to mild AV stenosis, suggesting that AV 
stenosis often is preceded by sclerosis in hypertension. 
12:48 p.m. 
1 IOSMP-167 Association of Cardiovascular Risk Factors to Aortic 
Valve Calcification as Quantified by Electron Beam 
Tomography 
Karsten Pohle, Merle Starke, Ralph MBffert, Dieter Ropers, Werner G. Daniel, Stephan 
Achenbach, University of Erlangen, Erlangen, Germany 
Electron beam tomography (EBT) allows the detection and exact quantification of calcifi- 
cations in coronary vessels (CC) and in the aortic valve (AVC). The aim of this study was 
to analyze the association of cardiovascular dsk factors, CC and AVC. 
Methods: We analyzed cardiac EBT data sets of 1000 consecutive patients (57.1+/-10 
years, 69% men) without an established diagnosis of coronary artery disease, which had 
been obtained for the detection of CC on an outpatient basis. In all patients, atheroscle- 
rotic risk factors (hyperlipidaemia [HL], hypertension [HTN], diabetes [DM], smoking) 
were documented. In all EBT studies, the amount of CC (“Agatston Score”) and of AVC 
(volumetric score) was measured. 
Results: In 17.7% of patients, AVC were found (volume score 41.6+/-219 mma). In 
82.9%, CC were present (Agatston Score 270.3+/s615). The amount of AVC and CC 
showed a weak but statistically significant correlation (wO.21, p<O.OOl). AVC were more 
frequently found in patients with CC as compared to patients without CC (20.5% vs. 
3.8%. pcO.OOl), in patients with HL [19.5% vs. 6.5%. p<O.OOl], HTN [21.7% vs. 13.9%, 
p=O.Ol] and DM [30.7% vs. 16.6%, p=O.O02]. No statistically significant correlation was 
observed for smoking [19.4% vs. 15.6%, p=O.ll]. AVC were found in 2.4% of patients 
without atherosclerotic risk factors, but in 33.3% of patients presenting all 4 nsk factors 
(pcO.001). The mean volume of AVC was significantly increased in patients with HL 
(48.0+/-237mm3 vs. 5.7 33mti, p<O.OOl) and DM (93.9+/-379mm9 vs. 37.5+/-201mm3, 
p=O.O3), while no such relationship was observed for smoking (46.0+/-222mm3 YS. 36.3+/ 
-216mm3, p=O.2) and HTN (52.1+/-259mm3 vs. 32.5+/-176mm3, p=O.l). 
Conclusion: In this study, a significant association was found between atherosclerotic 
risk factors, coronary calcifications and the presence and amount of calcifications of the 
aortic valve. 
1 :oo pm. 
1109MP-168 Risk Stratification in Mild and Moderate Aortic Stenosis 
by Assessment of Aortic Valve Calcification 
Raphael Rosenhek Ursula Klaar, Christine Scholten, Maria Heger, Harald Gabriel, 
Thomas Binder, Gerald Maurer, Helmut Baumganner, University of Vienna, Vienna, 
Austria 
Background: The degree of aortic valve calcification (AV-Calc) has been shown to be a 
significant predictor of outcome in severe aortic stenosis (AS). In addition, aortic sclero- 
sis has recently been reported to be associated with increased mortality. However, it 
remains unknown whether the,degree of AV-Cald is of prognostic value in mild and mod- 
erate AS. 
Methods: 176 consecutive pts. (73 F, age 58+/-19 yrs) with mild to moderate AS (peak 
aortic jet velocity (AV-Vel) between 2.5 and 4.0 m/s) were followed for 5lil8 mths. The 
degree of AV-Calc and other risk factors were assessed. The rate of hemodynamic pro- 
gression was determined and the clinical outcome analyzed. 
Results: During follow-up, 15 cardiac and 19 non-cardiac deaths occurred. Mortality was 
1.8 times higher than that of an age and gender _ matched control population (p<.OO5). 
Kaplan-Meier event-free survival for the entire pt. group, with endpoints defined as death 
(n=34) or aortic valve surgery (n=33) was 95+/-2 % at 1 yr, 75+/-3 % at 3 yrs. and 60+/-5 
% at 5 yrs. By multivariate analysis, moderate or severe AV-Calc, coronary artery dis- 
ease (CAD) and AV-Vel at entry were significant independent predictors of outcome 
(p<.OoOl, p<.OOl and pc.01, respectively). Event-free survival for patients with moderate 
or severe AV-Calc was 92+/-4% at 1 yr, 61+/-7% at 3 and 42+/-7% at 5 yrs versus 1 OO%, 
90+/-4% and 82+/-5% for patients with no or mild AV-Cak. Diabetes, hypercholesteremia 
and hypertension did not predict outcome. The rate of hemodynamic progression was 
significantly faster for pts. with event (0.43+/-0.04 m/s/yr) than for those without (0.14+/- 
0.02 m/s/yr, pc.0001). Of 129 pts. with a follow-up echocardiographic exam, 59 (46%) 
developed severe AS during follow-up. 
Conclusion: Rapid progression to severe AS and an increased mortality have to be con- 
sidered in mild and moderate AS. Particularly pts. with significant AV-Calc but also those 
with CAD and pts. with a rapid progression of the AV-Vel have a poor outcome. Serial 
Doppler studies and the assessment of AV-Cak are important for the management of 
these pts. as they identify high-risk pts. who require closer follow-up than currently rec- 
ommended. 
1109MP-169 
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Relation of Mitral Annular Calcification to 
Cardiovascular Risk Factors and Cardiovascular 
Mortality in Adults With Type 2 Diabetes: The Strong 
Heart Study 
Jennrfer E. Liu New York Hospital Weill Cornell Medical Center, New York, NY 
Background: Mitral annular calcificatron (MAC) is frequently seen on routine echocardio- 
gram in adults with type II diabetes (DM). However, whether MAC is associated with car- 
diovascular (CV) risk factors and subsequent CV events is not well defined. Methods: We 
compared two groups of DM American Indians based on the presence (n= 182) or 
absence (n= 1278) of MAC on echocardiogram. Results: DM with MAC were older (63 
vs. 60 years) with higher systolic blood pressure(l36 vs 133 mm Hg), higher total choles- 
terol (193 vs. 188 mg/dl) and higher urinary creatinine/albumin ratio (uacr) (1093 vs. 698, 
all p<O.OOl) as compared to DM without MAC. There was no difference in gender, body 
mass index or prevalence of smoking. DM with MAC had higher left ventricular (LV) 
mass (176 vs. 181 gm), higher prevalence of LV hypertrophy (18 vs. 10%) lower stress- 
corrected midwall shortening (98 vs. 103%) and lower mitral E/A ratio (0.75 vs. 0.81, all 
p<O.O05) as compared to DM without MAC. The prevalence of coronary heart disease 
and CV mortality and total mortality are as shown. 
On multivariate analysis adjustrng for age, systolic blood pressure, cholesterol and uacr, 
MAC was not found to be independently associated with prevalence of coronary heart 
disease, CV and total deaths. CONCLUSION: MAC is associated with abnormal LV 
structure and function in the DM population. The higher prevalence of coronary heart dis- 
ease and a higher total mortality in DM with MAC IS likely mediated by a larger burden of 
CV risk factors 
Prevalence of coronary heart disease 
No MAC 
7.2% 
MAC P value 
11.7% 0.03 
CV Death 3.9% 
All Death 8.3% 
1109MP-170 Impact of Systolic Hypertension and Impedance 
Lowering Drugs on Clinical Outcomes in Chronic 
Severe Aortic Regurgitation 
2.4% NS 
13.1% 0.05 
1:24 p.m. 
Phyllis G. Supine, Jeffrey S. Borer, Glare A. Hochreiter, Edmund M. Herrold, Richard B. 
Devereux, Mary J. Roman, Paul D. Kligfield, Elaine Dillingham, Weill Medical College of 
Cornell University, New York, NY 
Background: The prevalence of systolic hypertension (HTN) coexisting with aortrc regur- 
gitation (AR) and the impact of HTN on AR natural history are poorly defined. Such data 
are important: previous trials of impedance lowering drugs (ILRx) for AR were done 
largely in pts with HTN and suggest improvement in LV size and function. However, few 
data have elucidated ILRx effect on clinical outcome and ILRx effect in AR without HTN 
is unknown. To explore these issues, we retrospectively reviewed our ongoing prospec- 
tive study of AR natural history and outcome predictors. 
Methods: Among 73 unoperated pts with chronic severe AR (83% male, 44*15 yrs old at 
entry) who entered the study asymptomatic with normal LV ejection fraction (EF) at 
rest(r), we related HTN (history and/or study entry systolic blood pressure>l40) to subse- 
quent cardiac events (CE) during 7+4 event-free yrs. We also evaluated ILRx effect in pts 
with and without HTN. 
Results: At study entry, 29/73(40%) pts had HTN; 17/29(59%) pts with HTN and 3/ 
44(7%) without HTN were taking ILRx chronically (not protocol-mandated): diuretics(8 
pts), ACE inhibitors(5 pts), direct vasodilators(4 pts), combination ILRx(3 pts). During fol- 
lowup, 2 pts died suddenly, 17 pts developed CHF f subnl LVEFr and 5 developed subnl 
LVEFr alone. HTN predicted increased risk of CE (9.2%/yr vs 3.2%&r without HTN, 
p=.OO2) and remained predictive after adjustment for age and gender (p.z.02). Among pts 
with HTN. risk for CE was 4-fold greater in pts taking ILRx chronically(l5.5%/yr) vs those 
without chronic ILRx use(3.7%/yr, pc.02); among pts without HTN, risk was 0% with ILRx 
vs.3%/yr without (NS) but small subgroup size limits inferences in these pts. 
Conclusions: Systolic HTN occurs frequently in asymptomatic pts with chronic severe AR 
and portends a poor clinical outcome. Data were insufficient to evaluate individual drug 
classes but ILRx as a group do not mitigate the impact of HTN; at least some of these 
drugs may be deleterious. ILRx effect in pts without HTN remains unclear. Future 
research must determine why theoretically beneficial ILRx was ineffective for clinical out- 
come and, specifically, whether drug class, dose, etc., interact with clinical effect. 
I:36 pm. 
1109MP-171 Early Predictors of Mortality in Patients With 
Endocarditis 
Vivian Chu Christopher Cabell, Erin Kuniholm, Danny Benjamrn, John Engemann, Laura -1 
Meyer, Vance Fowler, Andrew Wang, Duke University Medical Center, Durham, NC 
Background: Infective endocarditis (IE) is associated with significant mortality, but prog- 
nostic factors remain poorly defined. We evaluated early prognostic factors in patients 
with IE, including severity of illness, to determine those independently associated with 
death. 
Methods: Clinical, microbrologic and echo data of patients with definite or possible IE by 
Duke criteria from 1996.2001 (n=351) were collected prospectively in the Duke IE data- 
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base. Patients with an echo performed within 7 days of admission (1x227) were included 
in this analysis. Acute physiology (APACHE II) scores, used as a marker of illness sever- 
ity, and heart failure (CHF) by Framingham criteria were determined retrospectively. Dif- 
ferences in clinical, microbiologic and echo variables between patients who died during 
index hospitalization and those who suwved to discharge were assessed by univariable 
analysis. Logistic regression analysis was used to determine characterist!cs Indepen- 
dently associated with in-hospital mortality. 
Results: Patients with IE had a median age of 60*16 years. There were 100 (44%) 
women. 76 (33%) had diabetes mellitus (DM). 64 (26%) were on hemodialysis, and 44 
(19%) had prosthebc valves. Median duration of symptoms prior to admission was 4 
days, and CHF was present in 73 (32%). 54 (24%) patients underwent cardiac surgery 
during index hospitakzatlon. Compared to patients who survived to discharge (n=l66). 
patients who died during admission (n=41, 16%) were similar with respect to CHF, echo 
findings, embolic events and rate of surgery. In contrast, patients that died were more 
likely to have DM (56% vs. 26%), higher median APACHE II score (17 vs. II), S. aureus 
InfectIon (77% vs. 33%), and persistent bacteremia (39% vs. 16%) (~~0.05 for each). In 
multivariable analysis, only DM (OR 2.6, 95% Cl 1.2-5.7) and S. aureus infection (OR 
3.1,95% Cl 1.2-7.6) were independently associated with in-hospital mortality. 
Conclusion: ControllIng for severity of illness, the early predictors of mortality in IE are 
the presence of DM and S.aureus infection. These results suggest a role for host-patho- 
gen factors in Identifying patients at high risk for mortality who may be targeted for 
aggressive care. 
I:48 pm 
1109MP-172 Left-Sided Valvular Disease in Carcinoid Syndrome: 
Underestimation Without Repetitive 
Echocardiographiee 
Nicolas Mansencal, Franck Digne, Emmanuel Mitry, Jean-Franqois Fonssier, Thverry 
Joseph, Pascal Lacombe, Guillaume Jondeau, Philippe Rougler, Olivia Dubourg, 
Hhpital Ambroise Park, Boulogne, France 
Background: Right-sided valvular disease is well known iri carcinoid syndrome but little is 
known about the left-sided valvular disease. The aim of our study was to assess the inci- 
dence of both right and left-sided valvular diseases and to determine the role of patent 
foramen wale (PFO) with this left-sided valvular disease. 
Methods: Sixty-three consecutwe trans-thoracic echocardiographies (TTE) have been 
performed in 26 pts (mean age 59 * 6 years, 54% women) presenting with carcinoid syn- 
drome. The echocardiographic following parameters were assessed: 1) right-sided valvu- 
lar disease, 2) left-sided valvular disease, 3) right to left shunting through a patent 
foramen wale (PFO +) using contrast echocardlography at rest and after cough test or 
vasa1va rnane”“er. 
Results: Mean follow-up was 21 * 20 months. At control, TrE revealed 7 pts (27%) with 
right-sided valvular carcinoid disease (RVCD), 3 pts (12%) with left-sided valvular carci- 
nold disease (LVCD) and 8 PFO + (31%). At the end of follow-up, the incidence of 
RVCD, LVCD and PFO + was 36% (10 pts), 31% (6 pts) and 36% (10 pts) respectively. 
All patients with RVCD and PFO + (7 patients) exhiblted progresslo” or new appearance 
of left-sided valvular disease. Six patients (75%) had both LVCD and PFO +. 
Conclusion: According to follow-up, our data suggest that the incidence of left-slded val- 
vular injury might be underestimated in carcinoid syndrome without repetitive echocar- 
diographles. PFO + resulting in right to left shunting seems to be a major factor of left- 
sided valvular ~n]ury and should be systematically researched in carcinoid syndrome. 
ORAL CONTRIBUTIONS 
824F0 Featured Oral Session...Emerging 
Concepts in Calcific Aortic Valve 
Stenosis 
Monday, March 31, 2003, 2:00 p.m.-3:30 p.m. 
McCormick Place, Room S403 
2:15 p.m. 
824FO-2 Atorvaetatin Inhibits Aortic Valve Calcification in an 
Experimental Model of Chronic Hypercholeeterolemia 
via Nonlipid Lowering Effects 
Nalini M. Raiamannan, Malayannan Subramaniam. Margaret Spring&t. Marek Neikrasz. 
Stuart R. Stock, Konstantine I. Ignatiev, Joseph McConnell, Ravinder Singh, Neil Stone. 
Robert 0. Bonow, Thomas C. Spelsberg, Northwestern University, Chicago, IL, Mayo 
Clinic, Rochester, MN 
Intro: Calcific aortic valve disease is the third most common indication for aortic valve 
(AV) replacement I” the USA. To further understand the cellular mechanisms of calcific 
aortic stenosis, we tested a model of chronic experimental hypercholesterolemia for cal- 
cification and also the non-lipid lowering effects of atorvastabn in the AV. Methods: Rab- 
bits (n=46) were treated for 3 months: Group I: normal diet, Group II: 0.5% (w/w) chol 
diet, and Group III: 0.5% (w/w) chol diet + atow (3mglkgiday). Masson Trichrome (MT) 
stain was performed for mineralization. Serum chol and high-sensitwlty C-reactwe pro- 
tan (hsCRP) levels were obtained by standard assays. Serum nrtrlte levels were mea- 
sured with a nitric oxide analyzer. lmmunoblots and immunohistochemistry were 
performed to measure the eNOS protein. MicroCT scans were performed for evaluation 
of calcification in the AV. Results: There was an increase in chol. hsCRP and calcification 
in Group II AV compared to Group I. Atorv inhibited calcification in the AV as assessed 
by micro-CT. Serum nitrite levels, eNOS protein expression (3.fold) and eNOS local~za- 
tion were decreased in Group II AV and increased in the Group Ill. MT stain demon- 
strated mineralization in the Group II AV. Concl: This finding of calcification in the AV 
during chronic experimental hyperchol provides evidence of bone mineralization in the 
aorl~c valve. Furlhermore, this bone mineralization is inhibited by atorv and may be medi- 
ated by anti-inflammatory effects of atorv. 
Chol (mgldl) 
hsCRP (mg/dl) 
Nitrites (nM) 
Group I 
45k5.6 
0.03*0.005 
994.67+/-392.51 
Group II 
1726i 637’ 
0.41*0.19 ’ 
196.17+/-106.83^*’ 
Group III 
1066r503 
0.04* 0.04” 
745+/-340.7Y’ 
2:30 p.m. 
824FO-3 Tumor Necrosis Factor Alpha Induces Calcification of 
Aortic Valve Myofibroblaete 
Jens J. Kaden Aslihan Sarikoc. Refika Kilic, Karl K. Haase, Carl-Erik Dempfle, Martin 
Borggrefe, University Hospital Mannheim, Mannheim, Germany 
Background:Tumor necrosis factor alpha (TNF) induces calcification of arterial smooth 
muscle cells in vitro. Calcific aortic stenosis, the most prevalent heart valve disease in 
the elderly, is characterized by massive tissue calafication. We have shown recently that 
TNF is upregulated in stenotic aortic valves, and that it IS associated with the remodeling 
of the extracellular matrix in this disorder. The influence of TNF on the pathogenesis of 
valvular calcification is unknown. 
Methods: Human aortlc valve myofibroblasts were isolated from explanted aortic valves. 
Confluent cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 
10% fetal calf serum, 50 mg/mL ascorbic acid, and 50 mmoUL beta-glycerophosphate, 
with and without 100 nglmL TNF. After 21 days, calcified cell nodules were counted. In 
total cell lysates, the expression of bone-type alkaline phosphatase and osteocalcin were 
assessed by wnmunoassay, alkaline phosphatase activity was measured by a kinetic 
assay, and calcium concentrations were determined by the cresolphthalein complexone 
method. 
Results: Cells treated wth TNF showed a 19-fold increase in nodule formation as com- 
pared to control. In cell lysates, Incubation with TNF resulted in a 20-fold increase in 
bone-type alkaline phosphatase expression, a 7-fold increase in osteocalcin expression, 
a 3.fold increase in alkaline phosphatase activity and a 3-fold increase in calcium con- 
centration as compared to control. 
Conclusion: TNF induces en osteoblast-like phenotype in cultured human aortic valve 
myofibroblasts in vitro, es indicated by increased nodule formatton. expression of osteo- 
blast-associated genes and calcification. These results suggest that valvular calclficahon 
in cakific aortic stenosis may be actively regulated, involving an inflammatory process. 
This could could be a potential target for modification of valvular calcification in calcific 
aortic stenosis. 
2:45 pm 
824FO-4 Relation of kortic Valve Calcification With 
Cardiovascular Risk Factors and Antiinflammatory 
Gene Polymorphisms in Patients With Degenerative 
Calcific Aottic Stenosis 
Jan R. Ortlepg Fabian Schmitz, Vera Mevissen, Stephan Weil3, Richard Dronskowskl, 
Klaus Zerres, Christian Weber, Riidiger Autschbach, Bruno Messmer, Peter Hanrath, 
Rainer Hoffman”, University Hospital of Aachen, Aachen, Germany, lnstltute of lnorganlc 
Chemistry, RWTH Aachen. Aachen. Germany 
Background: Calclficatlon of the aorilc valve mtght be influenced by the prevalence of 
cardiovascular risk factors (CRF), whereas the influence of genetic factors remains 
uncertain. 
Methods: [Ca5 (P04)30H] of 190 excised aortic valves with degenerative calcific aortic 
stenosis was determined using calcium atomic absorption analysis. Left heart catheter- 
ization, assessment of CRF and genotyping of the antiinflammatory lnterleukln 10 and 
chemokine receptor CCR5 polymorphisms were performed. 
Results: There was a positive correlation of calciftcation (quIntlIes) with the mean gradi- 
ent across the aortic valve (44 * 14, 52 * 16, 54 * 16.61 f 15,68 * 19 mmHg; pcO.001). 
Males had a hither dearee of calcification than females (26.2 * 8.9 versus 20.6 + 9.4 
mass%; p<O.OOl), des;te having the same mean gradient across the aortic valve (56 * 
17 versus 56 f 19 mmHo: o=O.9551. None of the investiaated CRF was associated with 
_ . I  
the degree of calcification. lnterleukin 10 promotor polymorphisms -1062. -619, and -592 
were significantly associated with the degree of calcification (haplotypes: 17.9 * 9.0 ver- 
sus 24 5 f 6.3 versus 25.4 * 9 4 mass%; pcO.001). This was pronounced if certain allele 
carriers had also the CCA5 D32 allele (haplotypes plus CCRB: 17.9 * 9.0 versus 24.5 r 
6.5 versus 27.5 r 10.9 mass%; p<O.oOl). 
Conclusion: CRF do not determlne the amount of aortic valve calcification. However, 
gender and genetic polymorphism of the interleukin 10 and CCR5 gene are associated 
with the degree of aortic valve calcification. 
